The results revealed that high mRNA expression of ADCY1, ADCY2, and ADCY5 were statistically related to better OS in Glioma patients with P < 0.01, compared with the low expression groups respectively (Fig. 2A). Here, ADCY5 is linked to central nervous system cancer.